These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31516059)

  • 1. Role of anti-DNA auto-antibodies as biomarkers of response to treatment in systemic lupus erythematosus patients: hypes and hopes. Insights and implications from a comprehensive review of the literature.
    Bragazzi NL; Watad A; Damiani G; Adawi M; Amital H; Shoenfeld Y
    Expert Rev Mol Diagn; 2019 Nov; 19(11):969-978. PubMed ID: 31516059
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of biological treatments on the anti-dsDNA and anti-nucleosome tests.
    Infantino M; Grossi V; Benucci M; Li Gobbi F; Damiani A; Manfredi M
    Lupus; 2018 Jan; 27(1):40-48. PubMed ID: 28587585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus.
    Tydén H; Lood C; Gullstrand B; Jönsen A; Ivars F; Leanderson T; Bengtsson AA
    Lupus; 2017 Feb; 26(2):139-149. PubMed ID: 27407135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-nucleosome antibodies in patients with systemic lupus erythematosus: potential utility as a diagnostic tool and disease activity marker and its comparison with anti-dsDNA antibody.
    Saigal R; Goyal LK; Agrawal A; Mehta A; Mittal P; Yadav RN; Meena PD; Wadhvani D
    J Assoc Physicians India; 2013 Jun; 61(6):372-7. PubMed ID: 24640201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis.
    Bizzaro N; Villalta D; Giavarina D; Tozzoli R
    Autoimmun Rev; 2012 Dec; 12(2):97-106. PubMed ID: 22810055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-dsDNA antibodies in systemic lupus erythematosus: A combination of two quantitative methods and the ANA pattern is the most efficient strategy of detection.
    Almeida González D; Roces Varela A; Marcelino Rodríguez I; González Vera A; Delgado Sánchez M; Aznar Esquivel A; Casañas Rodríguez C; Cabrera de León A
    J Immunol Methods; 2015 Dec; 427():30-5. PubMed ID: 26407840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-dsDNA titre in female systemic lupus erythematosus patients: relation to disease manifestations, damage and antiphospholipid antibodies.
    Gheita TA; Abaza NM; Hammam N; Mohamed AAA; El-Gazzar II; Eissa AH
    Lupus; 2018 Jun; 27(7):1081-1087. PubMed ID: 29460701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Petri MA; van Vollenhoven RF; Buyon J; Levy RA; Navarra SV; Cervera R; Zhong ZJ; Freimuth WW;
    Arthritis Rheum; 2013 Aug; 65(8):2143-53. PubMed ID: 23754628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmunity against nucleosomes and lupus nephritis.
    Van Bruggen MC; Kramers C; Berden JH
    Ann Med Interne (Paris); 1996; 147(7):485-9. PubMed ID: 9092359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases].
    Quattrocchi P; Barrile A; Bonanno D; Giannetto L; Patafi M; Tigano V; Ferlazzo B
    Reumatismo; 2005; 57(2):109-13. PubMed ID: 15983634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-nucleosome, anti-chromatin, anti-dsDNA and anti-histone antibody reactivity in systemic lupus erythematosus.
    González C; Garcia-Berrocal B; Herráez O; Navajo JA; González-Buitrago JM
    Clin Chem Lab Med; 2004 Mar; 42(3):266-72. PubMed ID: 15080558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of methotrexate on improving serological abnormalities of patients with systemic lupus erythematosus.
    Miyawaki S; Nishiyama S; Aita T; Yoshinaga Y
    Mod Rheumatol; 2013 Jul; 23(4):659-66. PubMed ID: 23011357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus.
    Ho A; Magder LS; Barr SG; Petri M
    Arthritis Rheum; 2001 Oct; 44(10):2342-9. PubMed ID: 11665975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus.
    Suleiman S; Kamaliah D; Nadeem A; Naing NN; Che Maraina CH
    Int J Rheum Dis; 2009 Jul; 12(2):100-6. PubMed ID: 20374326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High titer anti-basement membrane antibodies in a subset of patients with pediatric systemic lupus erythematosus.
    Orjuela A; Suwanichkul A; Canter D; Minard CG; Devaraj S; Hicks MJ; Muscal E; Wenderfer SE
    Am J Nephrol; 2015; 41(3):241-7. PubMed ID: 25926050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker.
    Simón JA; Cabiedes J; Ortiz E; Alcocer-Varela J; Sánchez-Guerrero J
    Rheumatology (Oxford); 2004 Feb; 43(2):220-4. PubMed ID: 13130152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus.
    Arbuckle MR; James JA; Kohlhase KF; Rubertone MV; Dennis GJ; Harley JB
    Scand J Immunol; 2001; 54(1-2):211-9. PubMed ID: 11439169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at risk.
    Bijl M; Horst G; Bootsma H; Limburg PC; Kallenberg CG
    Ann Rheum Dis; 2003 Jun; 62(6):534-9. PubMed ID: 12759290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus.
    Chabre H; Amoura Z; Piette JC; Godeau P; Bach JF; Koutouzov S
    Arthritis Rheum; 1995 Oct; 38(10):1485-91. PubMed ID: 7575698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.